Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hyperlipoproteinemias

  Free Subscription


Articles published in Curr Opin Lipidol

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    January 2019
  1. AWAN ZA, Bondagji NS, Bamimore MA
    Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region.
    Curr Opin Lipidol. 2019 Jan 28. doi: 10.1097/MOL.0000000000000586.
    PubMed     Text format     Abstract available


  2. MINAME MH, Bittencourt MS, Nasir K, Santos RD, et al
    Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000573.
    PubMed     Text format     Abstract available


  3. TOMLINSON B, Hu M, Chow E
    Current status of familial hypercholesterolemia in Chinese populations.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000580.
    PubMed     Text format     Abstract available


    December 2018
  4. MATA P, Alonso R, Perez de Isla L
    Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
    Curr Opin Lipidol. 2018;29:445-452.
    PubMed     Text format     Abstract available


    June 2018
  5. TIETGE UJF
    PURE and simple? A new perspective on the impact of diet on hyperlipidemia and cardiovascular risk.
    Curr Opin Lipidol. 2018;29:273-274.
    PubMed     Text format    


    April 2018
  6. PAQUETTE M, Baass A
    Predicting cardiovascular disease in familial hypercholesterolemia.
    Curr Opin Lipidol. 2018 Apr 26. doi: 10.1097/MOL.0000000000000519.
    PubMed     Text format     Abstract available


    January 2018
  7. RABES JP, Beliard S, Carrie A
    Familial hypercholesterolemia: experience from France.
    Curr Opin Lipidol. 2018 Jan 31. doi: 10.1097/MOL.0000000000000496.
    PubMed     Text format     Abstract available


  8. SMYTH N, Ramsay M, Raal FJ
    Population specific genetic heterogeneity of familial hypercholesterolemia in South Africa.
    Curr Opin Lipidol. 2018 Jan 24. doi: 10.1097/MOL.0000000000000488.
    PubMed     Text format     Abstract available


  9. VOLTA A, Hovingh GK, Grefhorst A
    Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?
    Curr Opin Lipidol. 2018 Jan 19. doi: 10.1097/MOL.0000000000000489.
    PubMed     Text format     Abstract available


  10. PAQUETTE M, Genest J, Baass A
    Familial hypercholesterolemia: experience from the French-Canadian population.
    Curr Opin Lipidol. 2018 Jan 19. doi: 10.1097/MOL.0000000000000487.
    PubMed     Text format     Abstract available


    October 2017
  11. HOLVEN KB, Ulven SM, Bogsrud MP
    Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Curr Opin Lipidol. 2017;28:445-447.
    PubMed     Text format    


    July 2017
  12. BADIMON L, Padro T, Cubedo J
    Protein changes in non-LDL-lipoproteins in familial hypercholesterolemia: implications in cardiovascular disease manifestation and outcome.
    Curr Opin Lipidol. 2017 Jul 5. doi: 10.1097/MOL.0000000000000441.
    PubMed     Text format     Abstract available


    April 2017
  13. GRAHAM CA, Latten MJ, Hart PJ
    Molecular diagnosis of familial hypercholesterolaemia.
    Curr Opin Lipidol. 2017 Apr 29. doi: 10.1097/MOL.0000000000000430.
    PubMed     Text format     Abstract available


  14. MARTIN AC, Bell DA, Brett T, Watts GF, et al
    Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Curr Opin Lipidol. 2017 Apr 19. doi: 10.1097/MOL.0000000000000423.
    PubMed     Text format     Abstract available


  15. ROTONDO D, Davidson J
    Gene therapy, a promising treatment for familial hypercholesterolaemia.
    Curr Opin Lipidol. 2017;28:216-217.
    PubMed     Text format    


  16. ARSENAULT BJ, Perrot N, Couture P
    Does lifestyle contribute to disease severity in patients with inherited lipid disorders?
    Curr Opin Lipidol. 2017;28:177-185.
    PubMed     Text format     Abstract available


    March 2017
  17. CALANDRA S, Tarugi P, Bertolini S
    Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
    Curr Opin Lipidol. 2017 Mar 18. doi: 10.1097/MOL.0000000000000414.
    PubMed     Text format     Abstract available


    February 2017
  18. KINDT I, Mata P, Knowles JW
    The role of registries and genetic databases in familial hypercholesterolemia.
    Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000398.
    PubMed     Text format     Abstract available


  19. BOURBON M, Alves AC, Sijbrands EJ
    Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia.
    Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000404.
    PubMed     Text format     Abstract available


  20. HOPKINS PN, Lane SR
    Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.
    Curr Opin Lipidol. 2017 Feb 2. doi: 10.1097/MOL.0000000000000397.
    PubMed     Text format     Abstract available


    January 2017
  21. SANTOS RD
    Phenotype vs. genotype in severe familial hypercholesterolemia: what matters most for the clinician?
    Curr Opin Lipidol. 2017 Jan 5. doi: 10.1097/MOL.0000000000000391.
    PubMed     Text format     Abstract available


    December 2016
  22. HOPKINS PN
    Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
    Curr Opin Lipidol. 2016 Dec 24. doi: 10.1097/MOL.0000000000000388.
    PubMed     Text format     Abstract available


  23. KOCKX M, Kritharides L
    Hyperlipidaemia in immunosuppression.
    Curr Opin Lipidol. 2016;27:631-632.
    PubMed     Text format    


  24. NORMAN R, Watts GF, Weintraub W, Gidding SS, et al
    Challenges in the health economics of familial hypercholesterolemia.
    Curr Opin Lipidol. 2016;27:563-569.
    PubMed     Text format     Abstract available


    April 2016
  25. HIGGINS CA, Rees A
    Do the mechanisms by which LDL-c levels are reduced influence the extent of clinical benefit which subsequently accrues?
    Curr Opin Lipidol. 2016;27:207-8.
    PubMed     Text format    


  26. STENDER S, Tybjaerg-Hansen A
    Using human genetics to predict the effects and side-effects of drugs.
    Curr Opin Lipidol. 2016;27:105-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: